1. ACHKAR E., CAREY W. — The cost of surveillance for adenocarcinoma complicating Barrett’s esophagus.Am. J. Gastroenterol., 1988,83, 291–4.
2. BORRIE J., GOLDWATER L. — Columnar cell-lined esophagus, assessment of etiology and treatment: a 22 year experience.J. Thor. Cardiovasc. Surg., 1976,71, 825–34.
3. BOYCE H.W. — Hiatal Hernia and peptic Diseases of the Esophagus. Gastroenterologic Endoscopy. Sivak MV (Ed), W.B. Saunders Company, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo, 1987, pp 401–418.
4. BROSSARD E., MONNIER Ph., OLLYO J.-B., FONTOLLIET Ch., LÉVI F. — Serious complications-stenosis, ulcer and Barrett’s epithelium -develop in 21,6% of adults with erosive reflux esophagitis.Gastroenterology, 1991,100, A36.
5. CAMERON A.J., OTT B.J., PAYNE W.S. — The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus.N. Engl. J. Med., 1985,313, 857–9.